Luminex Corp develops and manufactures biological testing techniques and products for the diagnostics, pharmaceutical, and life science industries. Its products are grouped into instruments, consumables, software, and assays. The instruments business sells a range of analyzers and laboratory instruments. Consumables include a variety of microspheres that can carry the reagents of an enzymatic, genetic, or immunologic assay. Luminex’s primary software product, xPONENT, is used to enhance and automate the functions of its xMAP instruments. Its assays include respiratory viral, gastrointestinal pathogen, pharmacogenetics, cystic fibrosis, HSV, and specialty assays. Luminex generates the vast majority of its revenue in the United States.